Envestnet Asset Management’s Sarepta Therapeutics SRPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$427K Sell
24,998
-12,361
-33% -$211K ﹤0.01% 3815
2025
Q1
$2.38M Sell
37,359
-8,255
-18% -$527K ﹤0.01% 2606
2024
Q4
$5.55M Buy
45,614
+4,847
+12% +$589K ﹤0.01% 2035
2024
Q3
$5.09M Sell
40,767
-27,912
-41% -$3.49M ﹤0.01% 2091
2024
Q2
$10.9M Buy
68,679
+28,073
+69% +$4.44M ﹤0.01% 1499
2024
Q1
$5.26M Buy
40,606
+8,241
+25% +$1.07M ﹤0.01% 1940
2023
Q4
$3.12M Sell
32,365
-3,277
-9% -$316K ﹤0.01% 2197
2023
Q3
$4.32M Buy
35,642
+21,514
+152% +$2.61M ﹤0.01% 1897
2023
Q2
$1.62M Buy
14,128
+3,108
+28% +$356K ﹤0.01% 2413
2023
Q1
$1.52M Buy
11,020
+3,574
+48% +$493K ﹤0.01% 2378
2022
Q4
$965K Buy
7,446
+1,240
+20% +$161K ﹤0.01% 2675
2022
Q3
$686K Buy
6,206
+3,144
+103% +$348K ﹤0.01% 2826
2022
Q2
$230K Sell
3,062
-2
-0.1% -$150 ﹤0.01% 3503
2022
Q1
$239K Sell
3,064
-329
-10% -$25.7K ﹤0.01% 3577
2021
Q4
$306K Sell
3,393
-1,004
-23% -$90.5K ﹤0.01% 3402
2021
Q3
$407K Buy
4,397
+874
+25% +$80.9K ﹤0.01% 3103
2021
Q2
$274K Sell
3,523
-1,694
-32% -$132K ﹤0.01% 3340
2021
Q1
$389K Sell
5,217
-4,083
-44% -$304K ﹤0.01% 2994
2020
Q4
$1.59M Buy
9,300
+115
+1% +$19.6K ﹤0.01% 1906
2020
Q3
$1.29M Buy
9,185
+5,708
+164% +$802K ﹤0.01% 1867
2020
Q2
$558K Sell
3,477
-18
-0.5% -$2.89K ﹤0.01% 2359
2020
Q1
$342K Buy
3,495
+196
+6% +$19.2K ﹤0.01% 2489
2019
Q4
$426K Sell
3,299
-725
-18% -$93.6K ﹤0.01% 2548
2019
Q3
$303K Buy
4,024
+1,034
+35% +$77.9K ﹤0.01% 2666
2019
Q2
$454K Sell
2,990
-626
-17% -$95.1K ﹤0.01% 2445
2019
Q1
$431K Buy
3,616
+535
+17% +$63.8K ﹤0.01% 2435
2018
Q4
$336K Buy
+3,081
New +$336K ﹤0.01% 2367
2018
Q3
Sell
-1,021
Closed -$135K 2430
2018
Q2
$135K Buy
1,021
+13
+1% +$1.72K ﹤0.01% 1876
2018
Q1
$75K Sell
1,008
-82
-8% -$6.1K ﹤0.01% 2005
2017
Q4
$61K Buy
1,090
+60
+6% +$3.36K ﹤0.01% 2261
2017
Q3
$47K Buy
1,030
+459
+80% +$20.9K ﹤0.01% 2299
2017
Q2
$20K Buy
571
+158
+38% +$5.53K ﹤0.01% 2595
2017
Q1
$13K Sell
413
-162
-28% -$5.1K ﹤0.01% 2744
2016
Q4
$16K Buy
+575
New +$16K ﹤0.01% 2699